Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00778063 · ClinicalTrials.gov registry record · NA
Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
A NA study, sponsored by Ochsner Health System.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00778063 is a NA study that was terminated before completion, run by Ochsner Health System. The registered enrollment target is 40 participants.
The verdict
NCT00778063, a NA study, was terminated before completion, sponsored by Ochsner Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of intranasal dexmedetomidine to reduce the incidence of emergence delirium during general sevoflurane anesthesia in a pediatric population receiving pressure equalization tubes in one or more ear.
Interventions
- DRUG saline
- DRUG dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00778063
The ClinicalTrials.gov registry entry for NCT00778063 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ochsner Health System, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which saline is the first listed.
NCT00778063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00778063 about?
NCT00778063 is a clinical study titled "Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients". The purpose of this study is to evaluate the use of intranasal dexmedetomidine to reduce the incidence of emergence delirium during general sevoflurane anesthesia in a pediatric population receiving pressure equalization tubes in one or more ear.
What is the current status of trial NCT00778063?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2008-09. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00778063?
The interventions under investigation include: saline (DRUG), dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT00778063?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.